Malignant Melanoma Archive - Seite 18 von 19 - IOZK

Randomized trial of hyperthermia and radiation for superficial tumors

2005-05-01/in Breast Cancer, Hyperthermia, International Publications, Malignant Melanoma /von 2005-05-01 / J. Clin. Oncol. 2005 May;23(13):3079-85

Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results

2005-03-18/in International Publications, Malignant Melanoma /von 2005-03-18 / Vaccine 2005 Mar;23(17-18):2367-73

Melanoma immunotherapy: past, present, and future

2005-01-01/in International Publications, Malignant Melanoma /von 2005-01-01 / Curr. Pharm. Des. 2005;11(27):3461-73

Comparison of the anti-tumor effects of various whole-body hyperthermia protocols: correlation with HSP 70 expression and composition of splenic lymphocytes

2005-01-01/in Hyperthermia, International Publications, Malignant Melanoma /von 2005-01-01 / Immunol. Invest. 2005;34(3):245-58

Phase I/II trial of melanoma patient-specific vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: planned interim analysis

2004-10-01/in International Publications, Malignant Melanoma /von 2004-10-01 / Cancer Biother. Radiopharm. 2004 Oct;19(5):658-65

The impact of surgery and mild hyperthermia on tumor response and angioneogenesis of malignant melanoma in a rat perfusion model

2004-08-23/in Hyperthermia, International Publications, Malignant Melanoma /von 2004-08-23 / BMC Cancer 2004 Aug;4:53

[Antitumor research on mouse melanoma with combined application of Newcastle disease virus and its HN gene]

2004-08-01/in International Publications, Malignant Melanoma /von 2004-08-01 / Ai Zheng 2004 Aug;23(8):910-3

Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage III and IV patients

2004-07-10/in International Publications, Malignant Melanoma /von 2004-07-10 / Int. J. Cancer 2004 Jul;110(5):730-40

Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients

2003-10-15/in Dendritic Cells, International Publications, Malignant Melanoma /von 2003-10-15 / J. Clin. Oncol. 2003 Oct;21(20):3826-35

Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2

2003-10-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2003-10-01 / Melanoma Res. 2003 Oct;13(5):521-30